跳至主要内容
临床试验/TCTR20240704004
TCTR20240704004已完成3 期

Efficacy of single-session focused extracorporeal shockwave therapy in patients with moderate-degree carpal tunnel syndrome versus steroid injection therapy A single-blind randomized controlled trial

Faculty of Medicine, Srinakharinwirot University0 个研究点目标入组 36 人开始时间: 2024年7月4日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
36

研究概览

简要总结

There was no significant difference in overall efficacy between focused extracorporeal shockwave therapy and steroid injections for moderate carpal tunnel syndrome. However, single-session fESWT demonstrated greater pain improvement at the 12th week compared to steroid injections, suggesting it may be a preferable option for patients concerned about steroid side effects.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Inclusion criteria 1) Symptoms include numbness or pain in the palm of the hand, plus positive findings from Phalen's, Tinel's and Median compression's test 2) Patients diagnosed with moderate carpal tunnel syndrome by electrodiagnosis show a reduction in conduction velocity of both sensory and motor fibers of the median nerve and/or a reduction in SNAP amplitudes to lower than 50% of normal values. [4] 3) The patient is 18 years old and over. And 4) A new patient who has not been treated with a steroid injection or other treatments, such as ultrasound therapy.

排除标准

  • 1) History of physical therapy treatment in the previous six months 2) Contraindications for fESWT such as pacemarker implantation, pregnancy 3) Refusal to participate in the study.

研究者

发起方
Faculty of Medicine, Srinakharinwirot University

相似试验